Vertaling van "agent or other " (Nederlands → Frans) :

TERMINOLOGIE

blootstelling aan Agent Orange
exposition à l'agent orange

IN-CONTEXT TRANSLATIONS

M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, -0,7 5,4 48.607.976 2,8 NON-STEROIDS C09D ANGIOTENSIN II ANTAGONISTS, COMBINATIONS 16,7 29,3 48.458.787 23,2 C08C SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY 4,8 10,5 47.845.796 8,1 VASCULAR EFFECTS L02B HORMONE ANTAGONISTS AND RELATED AGENTS 18,1 16,3 40.001.905 12,5 C01D VASODILATORS USED IN CARDIAC DISEASES -5,3 -0,3 37.257.508 -1,4 B02B VITAMIN K AND OTHER HEMOSTATICS x x 35.730.154 x N06D ANTI-DEMENTIA DRUGS 12,9 12,5 30.096.154 10,2 L02A HORMONES AND RELATED AGENTS -2,3 1,4 29.043.416 -0,3 N04B DOPAMINERGIC AGENTS 11,0 11,6 27.632.755 9,9 L01X OTHER ANTINEOPLASTIC AGENTS 11,6 23,7 26.993.829 15,7
INHALANTS M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, -0,7 5,4 48.607.976 2,8 NON-STEROIDS C09D ANGIOTENSIN II ANTAGONISTS, COMBINATIONS 16,7 29,3 48.458.787 23,2 C08C SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY 4,8 10,5 47.845.796 8,1 VASCULAR EFFECTS L02B HORMONE ANTAGONISTS AND RELATED AGENTS 18,1 16,3 40.001.905 12,5 C01D VASODILATORS USED IN CARDIAC DISEASES -5,3 -0,3 37.257.508 -1,4 B02B VITAMIN K AND OTHER HEMOSTATICS x x 35.730.154 x N06D ANTI-DEMENTIA DRUGS 12,9 12,5 30.096.154 10,2 L02A HORMONES AND RELATED AGENTS -2,3 1,4 29.043.416 -0,3 N04B DOPAMINERGIC AGENTS 11,0 11,6 27.632.755 9,9 L01X OTHER ANTINEOPLASTIC AGENTS 11,6 23,7 26.993.829 15,7

62. Evans RS, Pestotnik SL, Classen DC, Clemmer TP et al: A computer-assisted management program for antibiotics and other anti-infective agents.
62. Evans RS, Pestotnik SL, Classen DC, Clemmer TP et al : A computer-assisted management program for antibiotics and other anti-infective agents.

The in vitro identification of MRSA comprises three features: the identification of S. aureus, the determination of oxacillinresistance (detection and confirmation), and the antimicrobial susceptibility testing (AST) for other antimicrobial agents.
L'identification in vitro de MRSA comporte trois aspects: l'identification de S. aureus, la détermination de la résistance à l’oxacilline (dépistage et confirmation) et le test de sensibilité antimicrobienne (AST, pour « antimicrobian susceptibility testing ») à d’autres agents antimicrobiens.

The safe handling74, transport and temporary storage of meatand-bone meal which may be contaminated with a BSE agent or other pathogens.
The safe handling, transport and temporary storage of meat-andbone meal which may be contaminated with a BSE agent or other pathogens.